Theratechnologies Inc. - Asset Resilience Ratio

Latest as of May 2025: 1.80%

Theratechnologies Inc. (TH) has an Asset Resilience Ratio of 1.80% as of May 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Theratechnologies Inc. PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CA$924.00K

≈ $668.41K USD Cash + Short-term Investments

Total Assets

CA$51.27 Million

≈ $37.09 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (1999–2024)

This chart shows how Theratechnologies Inc.'s Asset Resilience Ratio has changed over time. See Theratechnologies Inc. balance sheet quality to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Theratechnologies Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Theratechnologies Inc. stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CA$462.00K	0.9%
Short-term Investments	CA$462.00K	0.9%
Total Liquid Assets	CA$924.00K	1.80%

Asset Resilience Insights

Limited Liquidity: Theratechnologies Inc. maintains only 1.80% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.

Theratechnologies Inc. Industry Peers by Asset Resilience Ratio

Compare Theratechnologies Inc.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Spyre Therapeutics Inc. NASDAQ:SYRE	Biotechnology	84.34%
3SBio Inc F:83B	Biotechnology	10.64%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	20.15%
Jiangxi Fushine Pharmaceutical Co Ltd SHE:300497	Biotechnology	0.02%
Novavax Inc NASDAQ:NVAX	Biotechnology	53.87%
BB Biotech AG SW:BION	Biotechnology	0.05%

Annual Asset Resilience Ratio for Theratechnologies Inc. (1999–2024)

The table below shows the annual Asset Resilience Ratio data for Theratechnologies Inc..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-11-30	13.96%	CA$7.45 Million ≈ $5.39 Million	CA$53.34 Million ≈ $38.59 Million	-2.22pp
2023-11-30	16.18%	CA$12.58 Million ≈ $9.10 Million	CA$77.77 Million ≈ $56.26 Million	-3.58pp
2022-11-30	19.76%	CA$18.43 Million ≈ $13.33 Million	CA$93.26 Million ≈ $67.46 Million	-13.72pp
2021-11-30	33.48%	CA$39.91 Million ≈ $28.87 Million	CA$119.21 Million ≈ $86.24 Million	+17.44pp
2020-11-30	16.04%	CA$16.06 Million ≈ $11.62 Million	CA$100.14 Million ≈ $72.44 Million	-4.32pp
2019-11-30	20.35%	CA$23.93 Million ≈ $17.31 Million	CA$117.56 Million ≈ $85.04 Million	+2.92pp
2018-11-30	17.43%	CA$19.39 Million ≈ $14.03 Million	CA$111.25 Million ≈ $80.48 Million	-38.28pp
2017-11-30	55.71%	CA$33.03 Million ≈ $23.89 Million	CA$59.29 Million ≈ $42.89 Million	+43.17pp
2016-11-30	12.54%	CA$4.95 Million ≈ $3.58 Million	CA$39.43 Million ≈ $28.52 Million	+4.93pp
2014-11-30	7.61%	CA$2.17 Million ≈ $1.57 Million	CA$28.51 Million ≈ $20.62 Million	+7.21pp
2013-11-30	0.40%	CA$93.25K ≈ $67.45K	CA$23.40 Million ≈ $16.93 Million	-0.01pp
2012-11-30	0.41%	CA$150.00K ≈ $108.51K	CA$36.58 Million ≈ $26.46 Million	-1.01pp
2011-11-30	1.42%	CA$728.26K ≈ $526.81K	CA$51.20 Million ≈ $37.04 Million	-1.17pp
2010-11-30	2.60%	CA$1.82 Million ≈ $1.32 Million	CA$70.28 Million ≈ $50.84 Million	-11.85pp
2009-11-30	14.44%	CA$9.49 Million ≈ $6.86 Million	CA$65.70 Million ≈ $47.52 Million	-5.79pp
2008-11-30	20.23%	CA$8.82 Million ≈ $6.38 Million	CA$43.60 Million ≈ $31.54 Million	-16.59pp
2007-11-30	36.82%	CA$27.45 Million ≈ $19.86 Million	CA$74.55 Million ≈ $53.93 Million	+1.46pp
2006-11-30	35.36%	CA$15.79 Million ≈ $11.42 Million	CA$44.65 Million ≈ $32.30 Million	+12.03pp
2005-11-30	23.33%	CA$10.72 Million ≈ $7.75 Million	CA$45.93 Million ≈ $33.23 Million	-2.44pp
2004-11-30	25.77%	CA$14.75 Million ≈ $10.67 Million	CA$57.23 Million ≈ $41.40 Million	-15.78pp
2003-11-30	41.55%	CA$30.28 Million ≈ $21.90 Million	CA$72.88 Million ≈ $52.72 Million	+13.72pp
2002-11-30	27.83%	CA$24.98 Million ≈ $18.07 Million	CA$89.78 Million ≈ $64.95 Million	-6.75pp
2001-11-30	34.58%	CA$31.25 Million ≈ $22.61 Million	CA$90.38 Million ≈ $65.38 Million	+2.10pp
2000-11-30	32.48%	CA$17.86 Million ≈ $12.92 Million	CA$54.99 Million ≈ $39.78 Million	-48.33pp
1999-11-30	80.81%	CA$14.87 Million ≈ $10.76 Million	CA$18.40 Million ≈ $13.31 Million	--

pp = percentage points

About Theratechnologies Inc.

TO:TH Canada Biotechnology

Market Cap

$148.68 Million

CA$205.53 Million CAD

Market Cap Rank

#17775 Global

#568 in Canada

Share Price

CA$4.47

Change (1 day)

-4.89%

52-Week Range

CA$3.20 - CA$4.70

All Time High

CA$58.28